Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0761
D

Improper Labeling of Aplisol Vial

Johnstown, Pennsylvania Survey Completed on 02-12-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to properly label a multi-use vial of Aplisol in the medication room, as observed during a survey. The manufacturer's directions for Aplisol, a tuberculin purified protein derivative, specify that vials in use for more than 30 days should be discarded due to potential oxidation and degradation affecting potency. However, during an inspection of the medication room refrigerator, a multi-use vial of Aplisol was found open and undated, indicating non-compliance with labeling requirements. An interview with an LPN at the time of the observation confirmed that the vial was not dated and should be discarded. Further confirmation from the Director of Nursing reiterated that the vial should have been dated upon opening and discarded once expired. This deficiency was noted under the regulations for pharmacy and nursing services, highlighting a lapse in the facility's adherence to proper medication labeling and storage protocols.

Plan Of Correction

The undated multi-use vial of Apisol was immediately disposed of, and another multi-use vial was replaced. Residents who have orders for Tuberculosis (TB) skin test have the potential to be affected. Baseline audit was completed to ensure that Apisol vials were dated for 28 days after opening. Licensed staff were educated by Staff Development Nurse on the process for dating prescribed items when opened and their recommended expiration date. Monitoring will be captured through auditing prescribed items for dating items when opened with their recommended expiration date. Audits will be conducted 2 times weekly for 4 weeks on 4 medications, then once monthly for 2 months on 4 medications. The audits will be conducted by the Staff Development Nurse or designee. Results of the audits will be provided to the Administrator and be presented for review at the monthly Quality Assurance Improvement Committee (QAPI) meeting monthly for a period of three months. Any revisions to the audit plan will be reviewed and implemented with the coordination of the Interdisciplinary team at QAPI Committee meeting.

An unhandled error has occurred. Reload 🗙